Arrive AI Announces Parkway Specimen Delivery Expansion With Hancock Health
Arrive AI has announced the next phase of its Hancock Health work, adding a Parkway Building delivery endpoint for scheduled and on-demand specimen transport to Hancock Regional Hospital’s laboratory.
Arrive AI (NASDAQ:ARAI) has announced an expansion of its autonomous specimen transport work with Hancock Health in Greenfield, Indiana. The company is adding an Arrive Point™ at the Parkway Building so specimens from the facility’s phlebotomy service can be moved to the Hancock Regional Hospital laboratory more frequently.
Under the new arrangement, Parkway staff will place specimens in the delivery endpoint. An autonomous ground robot already operating at Hancock Health will then make four to five scheduled pickup runs each day to the hospital laboratory.
After each Parkway collection, the robot will return to its existing on-demand route. The company said current transport routes will continue operating as they do today. The robot will also be available for on-demand trips involving time-sensitive specimens, including stat orders.
The laboratory will receive notifications when Parkway deliveries arrive, consistent with the existing transport route.
Parkway phlebotomy staff currently take specimens to the laboratory manually in large batches, typically two to three times a day. The centre serves walk-in patients, with about 60 patients a day and a morning rush from 8:00 to 10:00 a.m. that produces a large volume of specimens for analysis.
Arrive AI said the additional endpoint is designed to move smaller groups of specimens to the laboratory more often, rather than relying on larger batches. The stated aim is also to help specimens collected at Parkway reach the laboratory sooner.
Arrive AI’s autonomous specimen transport system has operated at Hancock Health since August 2025. The existing service carries specimens from an Arrive Point™ at the Hancock Health Sue Ann Wortman Cancer Center to the laboratory inside Hancock Regional Hospital.
An Arrive Point™ is described as a secure delivery endpoint that allows packages to be left for collection or picked up without both parties needing to be present. The system includes chain of custody in each handoff.
Arrive AI is providing installation, staff training and go-live support for the Parkway addition.
Matt Browning, COO of Hancock Health, said the laboratory team works best when specimens arrive in manageable groups during the day. He said the Parkway addition is designed to deliver specimens sooner and more steadily.
Dan O’Toole, founder, chairman and CEO of Arrive AI, said the Parkway work builds on Hancock Health’s experience with the Arrive Point network system since August 2025.
Hancock Health is an independent, full-service healthcare network serving East Central Indiana. Its network includes Hancock Regional Hospital, Hancock Physician Network and more than 30 other facilities.
Arrive AI describes itself as a physical AI and autonomous logistics infrastructure company. Its platform uses intelligent delivery endpoints to support drones, ground robotics and human couriers in the secure, asynchronous exchange of goods across logistics, healthcare and enterprise delivery.
Arrive AI announced the next phase of its work with Hancock Health, with an Arrive Point™ being added at the Parkway Building in Greenfield, Indiana. The endpoint will allow specimens from the Parkway phlebotomy service to be collected by an autonomous ground robot and carried to the Hancock Regional Hospital laboratory.
Arrive AI announced the expansion on November 9, 2026. The announcement concerns the planned addition of an Arrive Point™ at Parkway and the operation of scheduled and on-demand specimen deliveries to the Hancock Regional Hospital laboratory.
Hancock Health staff will place specimens in the new Arrive Point™, and an autonomous ground robot already operating at Hancock will carry them to the laboratory. The robot will return to its existing on-demand route after each Parkway run.
Arrive AI said the robot will make four to five scheduled pickup runs each day from the Parkway Building. The scheduled runs are intended to move smaller groups of specimens to the laboratory more often instead of transporting large batches.
Yes, the robot will also be available for on-demand runs for time-sensitive specimens, such as stat orders. The scheduled Parkway runs will operate alongside the robot’s existing on-demand route.
Parkway phlebotomy staff currently transport specimens to the laboratory manually in large batches, typically two to three times a day. The centre serves walk-in patients, with about 60 patients a day, including a morning rush from 8:00 to 10:00 a.m.
Arrive AI’s autonomous specimen transport system has operated at Hancock Health since August 2025. It has carried specimens from an Arrive Point™ at the Hancock Health Sue Ann Wortman Cancer Center to the laboratory inside Hancock Regional Hospital.
Arrive AI said the change is designed to give the laboratory smaller groups of specimens more often instead of large batches. It is also designed to help specimens drawn at Parkway reach the laboratory sooner.
The laboratory will receive arrival notifications for Parkway deliveries, as it does for the existing route. The Arrive Point™ is described as a secure delivery endpoint where packages can be dropped off or picked up without anyone waiting on the other end, with chain of custody built into each handoff.
Arrive AI is providing installation, staff training and go-live support for the addition of the Parkway Arrive Point™.
Matt Browning, COO of Hancock Health, said the laboratory team works best when specimens arrive in manageable groups throughout the day. He said adding Parkway to the system is designed to get specimens to the laboratory sooner and more steadily, and that this will help Hancock Health further improve patient care.
Arrive AI describes itself as a physical AI and autonomous logistics infrastructure company building infrastructure for autonomous logistics. Its network of intelligent delivery endpoints supports drones, ground robotics and human couriers, enabling secure, asynchronous exchange of goods across logistics, healthcare and enterprise delivery.
Arrive AI is identified in the announcement as trading on NASDAQ under the ticker symbol ARAI.